English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Angiogenesis is a physiological process consist in the sprouting of nascent vasculature from existing blood vessels. It is now widely recognized that angiogenic activity is also crucial in the progress of tumors and metastasis [1, 2]. Therefore, angiogenesis inhibition has become an appealing therapeutic strategy for cancer [3]. The tumors recruit blood vessels from the surrounding tissue to induce the growth of blood vessels to supply them with oxygen and nutrients. Basic fibroblast growth factor (FGF2), is one of the most potent proangiogenic proteins that has been shown to influence proliferation, migration, and differentiation of cells [4-7]. As it plays in important conditions, structural-functional relationship studies on FGF2 are of large interest. This growth factor needs to Abstract

Disruption of FGF2-Heparin-FGFR1 Complex Formation by Antiangiogenic Small Molecule Found In Silico